Table 10: Results of the Meta-Analysis by Sinno et al. (8) Combination Therapy Versus GpIIbIIIa.

30-Day All Cause Mortality (RR, 95% CI)	30-Day Reinfarction (RR, 95% CI)	Major Bleeding Events (RR, 95% CI)
1.47 (0.52 to 4.14), P=0.46	0.96 0.23 to 1.02), P=0.96	2.15 (1.17 to 3.94), P=0.01